Covid hospitalizations in the UK rose by more than 40% over a two-week period, adding approximately 400 patients to the NHS. This surge comes alongside an unexpectedly early increase in flu cases, sprking warnings about winter healthcare capacity.
The 40% jump in admissions and the West Midlands spike
New figures from the UK Health Security Agency (UKHSA) show that weekly hospital admissions for Covid climbed from 1.75 to 2.46 people per 100,000 in just fourteen days. This sharp increase is not distributed evenly across the country. According to the UKHSA, the West Midlands currently faces the highest risk with 3.55 admissions per 100,000 people, while the South West, including cities like Bath, reports the lowest rate at roughly 1.5 per 100,000.
The trajectory of infections suggests a significant acceleration. While August saw 1,374 confirmed cases and September saw 4,589, October has already recorded 3,942 cases. This suggests that October's final tally could potentially double the figures seen in September, indicating a rapid escalation as the weather cools.
Why the 85-and-over demographic faces 27 admissions per 100,000
The impact of the current wave is heavily concentrated among the elderly. People aged 85 and older are seeing nearly 27 admissions per 100,000 population, a rate that is more than ten times the national average. Data indicates that 13.5% of this age group are testing positive for Covid, compared to a general population positivity rate of 8.8%.
This vulnerability is mirrored in mortality rates. As reported by the UKHSA, Covid-related deaths increased by 46.4% in a single week, jumping from 28 to 41 in the period ending October 2. Professor Frankie Swords, the national medical director at NHS England, has warned that these are ominous signs for a healthcare system that is already strained.
The 'immunity gap' driving September's doubled flu tests
While Covid surges,flu is appearing earlier than typical seasonal patterns suggest. Positive flu tests in September were double the amount recorded during the same month last year. Professor Adam Finn of the University of Bristol notes that flu usually does not rise significantly until December, making this September spike an anomaly.
Professor Finn suggests this may be the result of a lingering "immunity gap" caused by Covid-19 lockdowns. Because social distancing prevented the spread of respiratory infections for nearly two years, many children and young adults did not develop the natural immunity usually acquired through seasonal flu exposure. Despite this early start, flu admissions have remained stable at 1.88 per 100,000, or about 1,070 patients per week.
The XFG 'Stratus' variant and the risk of drifted AH1N1
The current dominant Covid strain is known as XFG, or "Stratus ," which has been circulating in Europe and North America since the end of 2025. Dr Alex Allen, a consultant epidemiologist at the UKHSA, stated that XFG is closely related to strains that have existed for over a year and there is no evidence that it is spreading faster or causing more severe illness.
However, the flu situation is more volatile . A World Health Organisation (WHO) report has identified "drifted" AH1N1 viruses in Europe and the UK. Genetic drift can make vaccines less effectiive, and while last year's vaccines handled drifted strains well, health officials warn that it is impossible to predict which strain will dominate this winter.
The missing data on the NHS's 'busiest-ever summer'
Despite the detailed admission numbers, several critical pieces of information remain missing. Professor Frankie Swords of NHS England mentioned that the NHS just experienced its "busiest-ever summer," but the report provides no specific data on what caused that unprecedented summer pressure or how it has depleted current staffing levels.
Furthermore, while the UKHSA asserts that the autumn vaccine was specifically designed to protect against the XFG strain, there is currently no real-world efficacy data provided to confirm how well the new vaccine is performing against the "drifted" AH1N1 flu strains mentioned by the WHO. The report relies on the hope that the vaccine will be effective, rather than providing verified results from the current season.
Comments 0